TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS

Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LYSSIKATOS, JOSEPH P, MUNSON, MARK C, RAST, BRYSON, DELISLE, ROBERT KIRK, GROSS, STEFAN D, DAVIS, T. GREGG, TOPALOV, GEORGE T, HICKEN, ERIK JAMES, WRIGHT, A. DALE, CELESTE, LAURA L, ROBINSON, JOHN E, ZHAO, QIAN, KALLAN, NICHOLAS C, PHENEGER, JED, GRESCHUK, JULIE MARIE, ALLEN, SHELLEY, MARMSATER, FREDRIK P, JACKSON, LEILA J, SCHLACHTER, STEPHEN T
Format:	Patent
Sprache:	eng ; pol
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.